Pathological validation and prognostic potential of quantitative MRI in the characterization of pancreas cancer: preliminary experience

Author:

Klaassen Remy12ORCID,Steins Anne12ORCID,Gurney‐Champion Oliver J.34,Bijlsma Maarten F.25,Tienhoven Geertjan4,Engelbrecht Marc R. W.3,Eijck Casper H. J.6,Suker Mustafa6,Wilmink Johanna W.1,Besselink Marc G.7,Busch Olivier R.7,Boer Onno J.8,Vijver Marc J.8,Hooijer Gerrit K. J.8,Verheij Joanne8,Stoker Jaap3,Nederveen Aart J.3,Laarhoven Hanneke W. M.1ORCID

Affiliation:

1. Department of Medical Oncology Cancer Center Amsterdam Amsterdam UMC University of Amsterdam The Netherlands

2. Laboratory for Experimental Oncology and Radiobiology Center for Experimental and Molecular Medicine Cancer Center Amsterdam Amsterdam UMC University of Amsterdam The Netherlands

3. Department of Radiology & Nuclear Medicine Cancer Center Amsterdam Amsterdam UMC University of Amsterdam The Netherlands

4. Department of Radiation Oncology Cancer Center Amsterdam Amsterdam UMC University of Amsterdam The Netherlands

5. Oncode Institute Amsterdam The Netherlands

6. Department of Surgery Erasmus Medical Center Rotterdam The Netherlands

7. Department of Surgery Cancer Center Amsterdam Amsterdam UMC University of Amsterdam The Netherlands

8. Department of Pathology Cancer Center Amsterdam Amsterdam UMC University of Amsterdam The Netherlands

Funder

KWF Kankerbestrijding

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3